In an independent analysis of SLC1A5 expression in the ccRCC The Cancer Genome Atlas (TCGA) dataset, we confirmed that high SLC1A5 mRNA expression correlates with reduced survival in patients with ccRCC (fig. This evidence concerns the gene SLC1A5 and nonpapillary renal cell carcinoma.